# XIFAXAN
> **NDA022554** · New Drug Application · Sponsor: SALIX PHARMS · Approved 2010-03-24
## Drug
- **FDA Application Number:** NDA022554
- **Application type:** New Drug Application
- **Brand name:** XIFAXAN
- **Generic name:** Rifaximin
- **Active ingredients:** RIFAXIMIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SALIX PHARMS
- **First approval:** 2010-03-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022554)
---
*AI Analytics · CC0 1.0*